FDA Grants De Novo Clearance for Reflow Medical's Spur Stent System

FDA grants De Novo Clearance for Reflow Medical's spur stent system

Reflow Medical's Spur Stent System gains FDA clearance, offering treatment options for chronic limb-threatening ischemia with its retrievable design.

FDA Grants De Novo Clearance For Reflow Medical's Spur® Peripheral Retrievable Stent System - Medical Device News Magazine

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with […]